Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil and Hepatitis B Vaccine Co-administration (FUTURE)
NCT00517309Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2001
- Primary completion
- Jun 2004
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in Cervical Cancer (CC), genital warts, sponsored by Merck & Co.. Started Dec 2001; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
Cervical Cancer (CC)genital warts
Beyond the preview
Go deeper on NCT00517309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517309.